| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |